Send to a Friend Font Size: Increase Decrease

Viking Global Investors

Viking Global Investors 's Portfolio

Last Updated on 5/16/11 @ 05:55pm

Ticker	# of Shares	Price	Value
	143,085,126	$195.32	$27,947,386,811
	120,000,000	$195.32	$23,438,400,000
	75,238,700	$195.32	$14,695,622,884
MU	4,424,339	$981.61	$4,342,975,406
STX	3,186,400	$931.04	$2,966,665,856
GE	7,138,176	$335.30	$2,393,430,413
V	7,140,286	$322.39	$2,301,956,804
	9,798,229	$195.32	$1,913,790,089
PM	9,055,492	$184.30	$1,668,927,176
	6,639,199	$195.32	$1,296,768,349
View Additional Portfolio Information »

Viking Global Investors is a long/short equity hedge fund. The fund employs a bottom-up fundamental stock-picking strategy for its investments in equities in the U.S. and Europe. It focuses on the financial, telecommunication, media, technology, and consumer sectors. Viking Global Investors is based in New York and was founded in October, 1999 by Andreas Halvorsen, David Ott, and Brian Olson.

Messers. Halvorsen, Ott, and Olson worked together at Tiger Management Corp. All three left Tiger in early 1999.

Login to help us fill in information about this entity.

View Older Stories View More Recent Stories

Aug 14, 2025 05:35PM Form SCHEDULE 13G/A Trevi Therapeutics, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Aug 14, 2025 05:35PM Form SCHEDULE 13G/A APi Group Corp Filed by: VIKING GLOBAL INVESTORS LP
Aug 14, 2025 05:34PM Form SCHEDULE 13G/A Oric Pharmaceuticals, Filed by: VIKING GLOBAL INVESTORS LP
Aug 14, 2025 05:33PM Form SCHEDULE 13G/A REGAL REXNORD CORP Filed by: VIKING GLOBAL INVESTORS LP
Aug 14, 2025 05:33PM Form SCHEDULE 13G/A BIOMARIN PHARMACEUTICAL Filed by: VIKING GLOBAL INVESTORS LP
Aug 14, 2025 05:32PM Form SCHEDULE 13G/A Roivant Sciences Ltd. Filed by: VIKING GLOBAL INVESTORS LP
Aug 14, 2025 04:55PM Form 13F-HR VIKING GLOBAL INVESTORS For: Jun 30
Aug 12, 2025 10:15AM KeyBanc Reiterates Sector Weight Rating on Standard BioTools Inc (LAB)
Jul 24, 2025 07:56PM Form SCHEDULE 13G Fortive Corp Filed by: VIKING GLOBAL INVESTORS LP
Jul 1, 2025 07:50PM Form SCHEDULE 13D/A BridgeBio Pharma, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Jun 18, 2025 06:47PM Form SCHEDULE 13G Primo Brands Corp Filed by: VIKING GLOBAL INVESTORS LP
May 28, 2025 04:09PM ORIC Pharmaceuticals Inc. (ORIC) Announces $125 Million Private Placement at $6.50/sh
May 15, 2025 04:39PM Form SCHEDULE 13G/A Roivant Sciences Ltd. Filed by: VIKING GLOBAL INVESTORS LP
May 15, 2025 04:39PM Form SCHEDULE 13G/A Oric Pharmaceuticals, Filed by: VIKING GLOBAL INVESTORS LP
May 15, 2025 04:39PM Form SCHEDULE 13G/A Trevi Therapeutics, Inc. Filed by: VIKING GLOBAL INVESTORS LP
May 15, 2025 04:38PM Form SCHEDULE 13G ACUREN CORP Filed by: VIKING GLOBAL INVESTORS LP
May 15, 2025 03:48PM Form 13F-HR VIKING GLOBAL INVESTORS For: Mar 31
Apr 18, 2025 09:45AM Form SCHEDULE 13G REGAL REXNORD CORP Filed by: VIKING GLOBAL INVESTORS LP
Mar 12, 2025 04:28PM Form SCHEDULE 13D/A BridgeBio Pharma, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Mar 12, 2025 04:27PM Form SCHEDULE 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2025 04:58PM Form SCHEDULE 13G Sionna Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2025 04:51PM Form SCHEDULE 13G/A Longboard Pharmaceutical Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2025 04:51PM Form SCHEDULE 13G/A NewAmsterdam Pharma Co Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2025 04:50PM Form SCHEDULE 13G/A APi Group Corp Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2025 03:20PM Form 13F-HR VIKING GLOBAL INVESTORS For: Dec 31
Feb 11, 2025 08:04AM TruBridge (TBRG) Announces Two Directors to Join Its Board as a Part of Cooperation Agreements With Pinetree Capital and Ocho Investments
Jan 31, 2025 07:19PM Form SCHEDULE 13D/A BridgeBio Pharma, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Jan 31, 2025 07:18PM Form 144 BridgeBio Pharma, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Nov 14, 2024 04:33PM Form SC 13G/A Ginkgo Bioworks Holdings Filed by: VIKING GLOBAL INVESTORS LP
Nov 14, 2024 04:32PM Form SC 13G/A 4D Molecular Therapeutic Filed by: VIKING GLOBAL INVESTORS LP
Nov 14, 2024 04:33PM Form SC 13G/A Tourmaline Bio, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Nov 14, 2024 04:32PM Form SC 13G/A Edgewise Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP
Nov 14, 2024 04:32PM Form SC 13G/A PepGen Inc. Filed by: VIKING GLOBAL INVESTORS LP
Nov 14, 2024 04:32PM Form SC 13G/A Roivant Sciences Ltd. Filed by: VIKING GLOBAL INVESTORS LP
Nov 14, 2024 04:31PM Form SC 13G/A Verastem, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Nov 14, 2024 04:31PM Form SC 13G/A Viking Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP
Nov 14, 2024 04:01PM Form 13F-HR VIKING GLOBAL INVESTORS For: Sep 30
Nov 6, 2024 05:04PM Form SC 13D/A BridgeBio Pharma, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Nov 6, 2024 05:04PM Form SC 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
Oct 4, 2024 07:38AM Form D/A Viking Global Opportunit
Oct 4, 2024 07:35AM Form D/A Viking Global Opportunit
Oct 4, 2024 07:33AM Form D/A Viking Global Equities
Oct 4, 2024 07:30AM Form D/A Viking Global Equities
Oct 4, 2024 07:03AM Form D/A Viking Global Equities
Sep 30, 2024 04:29PM Form SC 13G BIOMARIN PHARMACEUTICAL Filed by: VIKING GLOBAL INVESTORS LP
Sep 3, 2024 04:11PM Form N-PX VIKING GLOBAL INVESTORS For: Jun 30
Aug 20, 2024 08:42PM Form SC 13D/A BridgeBio Pharma, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Aug 14, 2024 04:17PM Form 13F-HR VIKING GLOBAL INVESTORS For: Jun 30
Jul 15, 2024 04:18PM Form SC 13G Longboard Pharmaceutical Filed by: VIKING GLOBAL INVESTORS LP
Jun 18, 2024 05:06PM Form SC 13G/A APi Group Corp Filed by: VIKING GLOBAL INVESTORS LP

View More Recent Stories View Older Stories

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed